Robotic Process Automation (RPA) has emerged as a pivotal technology in the digital transformation of business processes. By employing software robots to execute rule-based, repetitive tasks, RPA ...
Robotic Process Automation (RPA) is a tool designed to assist, not replace, employees. It uses software bots to automate repetitive, rule-based tasks like data processing, report generation, and ...
UiPath Inc. today announced a preview of its upcoming Agent Builder tool as it outlined its vision to combine its expertise in robotic process automation with generative artificial intelligence models ...
UiPath Positioned Highest for Ability to Execute and Furthest for Completeness of Vision “The Magic Quadrant evaluated 13 enterprise RPA vendors to help enterprises make the best choice for their ...
Incorporating cognitive technologies with business process automation can bring significant gains in efficiency, revenue, and customer satisfaction — if it’s done right. Here’s how companies should ...
NEW YORK--(BUSINESS WIRE)-- UiPath (PATH), a global leader in agentic automation, today announced it has been positioned by Gartner, Inc. as a Leader in the 2025 Gartner® Magic Quadrant™ for Robotic ...
NEW YORK--(BUSINESS WIRE)-- UiPath (NYSE: PATH), a global leader in agentic automation, today announced it has been positioned by Gartner, Inc. as a Leader in the 2025 Gartner® Magic Quadrant™ for ...
Healthcare is big business in the U.S.: in 2021, healthcare spending reached nearly $4.3 trillion, accounting for more than 18% of GDP or an average of almost $13,000 per capita. This is due to a ...
PECOS, Texas — In Pecos, the city was facing potential staff shortages delays in their financial processing. Then, city manager, Charles Lino was approached with a potential solution: a new technology ...
UiPath Inc. (NYSE: PATH) is one of the worst-performing agentic AI stocks so far in 2026. Based on its January 2, 2026 close of $16.59 and its April 2, 2026 close of $11.24, the stock was down about ...
Adopting robotics in pharma boosts resilience, precision, and compliance. Demand grows globally with diverse drug portfolios ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果